These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 14727970)

  • 1. Pharmacotherapy of obesity: currently marketed and upcoming agents.
    Bays H; Dujovne C
    Am J Cardiovasc Drugs; 2002; 2(4):245-53. PubMed ID: 14727970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharmacological therapy of obesity].
    Pagotto U; Vanuzzo D; Vicennati V; Pasquali R
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacotherapy for obesity.
    Ioannides-Demos LL; Proietto J; McNeil JJ
    Drugs; 2005; 65(10):1391-418. PubMed ID: 15977970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacologic options for the treatment of obesity.
    Campbell ML; Mathys ML
    Am J Health Syst Pharm; 2001 Jul; 58(14):1301-8. PubMed ID: 11471477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-obesity drug development.
    Bays H; Dujovne C
    Expert Opin Investig Drugs; 2002 Sep; 11(9):1189-204. PubMed ID: 12225242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obesity drug therapy.
    Baretić M
    Minerva Endocrinol; 2013 Sep; 38(3):245-54. PubMed ID: 24126545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The pharmacotherapy of obesity].
    Budai KA; Mirzahosseini A; Noszál Béla ; Tóth G
    Acta Pharm Hung; 2015; 85(1):3-17. PubMed ID: 26137782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology of Obesity and Pharmacologic Treatment Options.
    Shettar V; Patel S; Kidambi S
    Nutr Clin Pract; 2017 Aug; 32(4):441-462. PubMed ID: 28632997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Past and present of antiobesity agents: focus on monoamine modulators.
    Khorassani FE; Misher A; Garris S
    Am J Health Syst Pharm; 2015 May; 72(9):697-706. PubMed ID: 25873617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New and emerging drug molecules against obesity.
    George M; Rajaram M; Shanmugam E
    J Cardiovasc Pharmacol Ther; 2014 Jan; 19(1):65-76. PubMed ID: 24064009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Recent progress and novel perspectives on obesity pharmacotherapy].
    Faria AM; Mancini MC; Melo ME; Cercato C; Halpern A
    Arq Bras Endocrinol Metabol; 2010 Aug; 54(6):516-29. PubMed ID: 20857056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Obesity: a review of currently used antiobesity drugs and new compounds in clinical development].
    Zieba R
    Postepy Hig Med Dosw (Online); 2007 Oct; 61():612-26. PubMed ID: 17971763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of antiobesity medications in patients with type 2 diabetes mellitus.
    Choussein S; Makri AA; Frangos CC; Petridou ET; Daskalopoulou SS
    Diabetes Obes Metab; 2009 Jul; 11(7):641-64. PubMed ID: 19236442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Drug treatment of obesity--current situation and perspectives].
    Hainer V
    Cas Lek Cesk; 2010; 149(11):513-9. PubMed ID: 21391349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New antiobesity agents in type 2 diabetes: overview of clinical trials with sibutramine and orlistat.
    Scheen AJ; Ernest P
    Diabetes Metab; 2002 Dec; 28(6 Pt 1):437-45. PubMed ID: 12522323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A risk-benefit assessment of anti-obesity drugs.
    Kolanowski J
    Drug Saf; 1999 Feb; 20(2):119-31. PubMed ID: 10082070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug treatment of obesity in cardiovascular disease.
    Charakida M; Finer N
    Am J Cardiovasc Drugs; 2012 Apr; 12(2):93-104. PubMed ID: 22292446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A benefit-risk assessment of sibutramine in the management of obesity.
    Nisoli E; Carruba MO
    Drug Saf; 2003; 26(14):1027-48. PubMed ID: 14583064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The "problem obesity": viewpoint of the internist].
    Guagnano MT; Manigrasso MR; Capani F; Davì G
    Ann Ital Chir; 2005; 76(5):407-11. PubMed ID: 16696212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Orlistat--a novel weight loss therapy.
    Lucas KH; Kaplan-Machlis B
    Ann Pharmacother; 2001 Mar; 35(3):314-28. PubMed ID: 11261530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.